Private Prescription Access: Skip NHS Waiting Lists
Private Wegovy vs Mounjaro UK: Why Choose Private Prescription?
The NHS route for weight management medications requires GP referral to specialist services, with typical waiting times exceeding 6 months. Private prescription removes these barriers entirely. For Wegovy vs Mounjaro UK patients, private access means starting treatment weeks or months earlier than NHS pathways. Both medications require identical clinical assessments — BMI ≥30 or BMI ≥27 with comorbidities — but private providers complete these assessments within days rather than months.
EverydayMeds supplies the same Novo Nordisk Wegovy dispensed by NHS pharmacies, but without referral delays. Our GPhC-registered pharmacy (#9012878) ensures identical quality standards to hospital pharmacy supplies. Private prescription costs are transparent and fixed, unlike NHS prescription charges that may increase annually. This approach suits patients who value time-sensitive access to prescription-only medicines.
Wegovy vs Mounjaro UK Pricing: Complete Cost Breakdown
Wegovy private prescription costs vary by dose strength throughout the escalation schedule. Starting at £79.99 for 0.25mg (weeks 1-4) with discount code FIRST40, costs increase to £209.99 for maintenance 2.4mg doses. Our Getting Started bundles provide convenience — the Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks. Returning customers benefit from code DOSE25 for ongoing supply.
Mounjaro pricing follows similar private prescription models but varies between providers. When comparing Wegovy vs Mounjaro UK costs, consider total treatment duration and dose escalation requirements. Both require 16+ week escalation periods before reaching maintenance doses. EverydayMeds' Ultimate Stability Trio provides 3 months of maintenance Wegovy 2.4mg supply for £649.99, ensuring consistent access without repeated ordering.
Clinical Evidence: Wegovy vs Mounjaro UK Trial Data
The STEP programme demonstrates Wegovy's efficacy in clinical trials, with participants achieving approximately 15% average weight loss at 68 weeks alongside reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). STEP 5 data shows sustained weight management at 2 years with continued treatment.
Mounjaro trials show different endpoints and populations, making direct comparison inappropriate. Both medications underwent rigorous MHRA assessment before UK licensing. Individual responses vary significantly, and your prescriber can help determine which option may suit your circumstances during clinical assessment.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones. This prescription-only medicine works on brain appetite centres, potentially reducing food cravings and promoting satiety after smaller meals. The weekly injection allows consistent hormone levels throughout the week. Dose escalation from 0.25mg to 2.4mg over 16 weeks helps minimise side effects while building therapeutic response. Unlike Mounjaro's dual GIP/GLP-1 action, Wegovy targets GLP-1 receptors exclusively, providing a well-established mechanism studied across multiple clinical programmes.
Private Prescription Ordering: 3-Minute Assessment Process
EverydayMeds' private prescription process eliminates traditional healthcare delays. Complete our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. UK-registered prescribers review applications within 3 working days (24 hours for express service). Once approved, genuine Novo Nordisk Wegovy ships via next-day cold-chain delivery, maintaining 2-8°C temperature requirements. No GP appointments, no specialist referrals, no months-long waiting lists — just direct access to prescription-only weight management treatment.
Storage and Practical Considerations: Wegovy vs Mounjaro UK
Wegovy offers storage advantages over Mounjaro for UK patients. Once removed from refrigeration, Wegovy remains stable at room temperature (below 30°C) for 6 weeks, compared to Mounjaro's 21-day limit. This flexibility suits UK travel and holiday requirements. Both use similar pen injection systems, but Wegovy's FlexTouch design provides dose confirmation clicks. Store unused pens at 2-8°C until first use, then continue refrigeration when possible. The 6-week room temperature window makes Wegovy particularly suitable for patients with irregular schedules or frequent travel.
Wegovy vs Mounjaro UK: Medication Mechanism Differences
The fundamental difference between these medications lies in hormone targeting. Wegovy (semaglutide) exclusively targets GLP-1 receptors, providing single-pathway appetite regulation. Mounjaro (tirzepatide) combines GIP and GLP-1 receptor activation, offering dual-mechanism action. Both require prescription-only access and identical clinical monitoring.
This mechanical difference doesn't determine superiority — individual patient factors influence which mechanism may prove more suitable. Some patients respond better to single-pathway GLP-1 action, whilst others may benefit from dual-hormone approaches. Your prescriber assessment considers medical history, concurrent medications, and personal circumstances when recommending Wegovy vs Mounjaro UK options.
Start Your Private Prescription Journey Today
Both Wegovy and Mounjaro are available through EverydayMeds private prescription service — your prescriber can help determine which option suits your circumstances. New customers use code FIRST40, whilst returning patients benefit from DOSE25 at checkout. Our clinical team provides ongoing support throughout your treatment journey, with prescription reviews and dose adjustments as needed. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment today. Skip NHS delays and access genuine prescription-only weight management treatment with professional clinical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
